Fourrts (india) Laboratories Private Limited — Atenolol Exporter Profile
Indian Pharmaceutical Exporter · #7 for Atenolol · $1.4M export value · DGFT Verified
Fourrts (india) Laboratories Private Limited is the #7 Indian exporter of Atenolol with $1.4M in export value and 51 verified shipments. Fourrts (india) Laboratories Private Limited holds a 3.5% market share in Atenolol exports across 5 countries. The company exports 17 pharmaceutical products worth $31.5M across 11 therapeutic categories.
Fourrts (india) Laboratories Private Limited — Atenolol Export Profile: Buyers & Destinations
Where Does Fourrts (india) Laboratories Private Limited Export Atenolol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $47.5K | 4 | 65.7% |
| NIGERIA | $20.8K | 2 | 28.8% |
| ZAMBIA | $4.0K | 1 | 5.5% |
Fourrts (india) Laboratories Private Limited exports Atenolol to 3 countries. The largest destination is UNITED KINGDOM accounting for 65.7% of Fourrts (india) Laboratories Private Limited's Atenolol shipments, followed by NIGERIA (28.8%) and ZAMBIA (5.5%). These destinations reflect Fourrts (india) Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Atenolol from Fourrts (india) Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NEW HEALTH SUPPLIES LTD | UNITED KINGDOM | $47.5K | 4 |
| UNIQUE PHARMACEUTICALS LTD | NIGERIA | $20.8K | 2 |
| M S KARIBU PHARMACEUTICALS LTD | ZAMBIA | $4.0K | 1 |
Fourrts (india) Laboratories Private Limited supplies Atenolol to 3 buyers globally. The largest buyer is NEW HEALTH SUPPLIES LTD (UNITED KINGDOM), followed by UNIQUE PHARMACEUTICALS LTD (NIGERIA) and M S KARIBU PHARMACEUTICALS LTD (ZAMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Atenolol Export Value and How Much Does Fourrts (india) Laboratories Private Limited Contribute?
India exported $33.3M worth of Atenolol through 3,681 shipments from 300 suppliers to 124 countries, serving 671 buyers globally. Fourrts (india) Laboratories Private Limited contributes $1.4M to this total, accounting for 3.5% of India's Atenolol exports. Fourrts (india) Laboratories Private Limited ships Atenolol to 3 countries through 3 buyers.
What Is the Average Shipment Value for Fourrts (india) Laboratories Private Limited's Atenolol Exports?
Fourrts (india) Laboratories Private Limited's average Atenolol shipment value is $28.0K per consignment, based on 51 shipments totaling $1.4M. The largest destination is UNITED KINGDOM (65.7% of Fourrts (india) Laboratories Private Limited's Atenolol exports).
How Does Fourrts (india) Laboratories Private Limited Compare to Other Indian Atenolol Exporters?
Fourrts (india) Laboratories Private Limited ranks #7 among 300 Indian Atenolol exporters with a 3.5% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($8.3M), UNICHEM LABORATORIES LIMITED ($4.8M), AUROBINDO PHARMA LTD ($4.1M). Fourrts (india) Laboratories Private Limited processed 51 shipments to 5 destination countries.
What Atenolol Formulations Does Fourrts (india) Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ATENOLOL 50MG TABLETS 2X14S | $24.9K | 1 |
| ATENOLOL 25MG TABLETS 2X14S | $22.6K | 1 |
| ATENOLOL TABLETS BP 100MG BETAFIL 100 QTY 52110X2X14S | $16.2K | 1 |
| ATENOLOL TABLETS BP 50MG BETAFIL 50 QTY 17775X2X14S | $4.6K | 1 |
| ATENOLOL TABLETS BP 50 MG BETAFIL 50 6599 X 10 X 10 S | $4.0K | 1 |
| ATENOLOL 25MG TABLETS 2X14S QP SAMPLE VALUE GBP 7 820 VALUE DECLARED FOR CUSTOMS PURPOSE ONLY | $0 | 1 |
| ATENOLOL 50MG TABLETS 2X14S QP SAMPLE VALUE GBP 7 600 VALUE DECLARED FOR CUSTOMS PURPOSE ONLY | $0 | 1 |
Fourrts (india) Laboratories Private Limited exports 7 distinct Atenolol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATENOLOL 50MG TABLETS 2X14S with 1 shipments worth $24.9K.
Regulatory Requirements: Exporting Atenolol to Key Markets
What Fourrts (india) Laboratories Private Limited must comply with to export Atenolol to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Fourrts (india) Laboratories Private Limited Compare to Nearest Atenolol Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | ZYDUS LIFESCIENCES LIMITED | $3.8M | 200 | 13 | $19.1K |
| 5 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $3.4M | 164 | 7 | $21.0K |
| 7 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ★ | $1.4M | 51 | 5 | $28.0K |
| 8 | STRIDES PHARMA SCIENCE LIMITED | $1.3M | 82 | 2 | $15.5K |
| 6 | LINCOLN PHARMACEUTICALS LTD | $1.1M | 21 | 5 | $50.0K |
Fourrts (india) Laboratories Private Limited ranks #7 among 300 Indian Atenolol exporters. Average shipment value of $28.0K compared to the market average of $111.2K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Atenolol Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 445 | 12.1% |
| NHAVA SHEVA SEA (INNSA1) | 394 | 10.7% |
| SAHAR AIR | 378 | 10.3% |
| MUNDRA SEA | 246 | 6.7% |
| JNPT/ NHAVA SHEVA SEA | 239 | 6.5% |
| JNPT | 229 | 6.2% |
| Bombay Air | 125 | 3.4% |
| DELHI AIR | 98 | 2.7% |
What Other Cardiovascular Products Does Fourrts (india) Laboratories Private Limited Export?
Fourrts (india) Laboratories Private Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Fourrts (india) Laboratories Private Limited's Atenolol Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Fourrts. The Israel-Iran conflict has led to disruptions in Middle Eastern trade routes, particularly affecting the Red Sea corridor. Major shipping lines have introduced 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effectively increasing the cost of exporting pharmaceuticals to key markets. (sgeexport.com)
Conversely, the recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable outlook. The FTA eliminates tariffs on approximately 97% of European exports, including pharmaceuticals, potentially doubling India's exports to the EU by 2032. This development provides Fourrts with an opportunity to expand its footprint in European markets, offsetting challenges in other regions. (en.wikipedia.org)
In the United States, the imposition of tariffs on pharmaceutical imports has prompted a reshoring of manufacturing. While this trend may reduce reliance on Indian generics, it also opens avenues for Indian companies to invest in U.S.-based facilities, thereby maintaining market access. Fourrts could consider strategic investments or partnerships to navigate this evolving landscape. (odrindia.in)
Fourrts (india) Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for sustaining export operations. The WHO's alert regarding the 'COLD OUT' syrup underscores the necessity for rigorous quality control and adherence to Good Manufacturing Practices (GMP). Indian pharmaceutical companies are increasingly investing in compliance automation and supply chain restructuring to meet the stringent requirements of markets like the EU and the U.S. (transdatanexus.com)
For Fourrts, maintaining and enhancing compliance protocols is essential to mitigate risks and capitalize on global market opportunities. Proactive engagement with regulatory bodies and continuous improvement in quality assurance processes will be critical in navigating the complex regulatory environment.
About Fourrts (india) Laboratories Private Limited
Fourrts (india) Laboratories Private Limited exports 17 products worth $31.5M. Beyond Atenolol, top products include Metformin, Ibuprofen, Paracetamol, Cetirizine, Naproxen. View the complete Fourrts (india) Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atenolol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atenolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Fourrts (india) Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 7 individual customs records matching Fourrts (india) Laboratories Private Limited exporting Atenolol, covering 7 formulations to 3 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 124+ countries, 671+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atenolol Export Data from Fourrts (india) Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Fourrts (india) Laboratories Private Limited's Atenolol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Fourrts (india) Laboratories Private Limited
Full Company Profile →
17 products · $31.5M total trade · 11 categories
Atenolol Stats
Company Overview
Top Products by Fourrts (india) Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Fourrts (india) Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atenolol. For current shipment-level data, contact TransData Nexus.